Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A

European Journal of Pharmacology
S ChoM Hadjiconstantinou

Abstract

After acute administration of the monoamine oxidase inhibitor clorgyline there is a reduction of aromatic L-amino acid decarboxylase and tyrosine hydroxylase activity in the mouse striatum. Similar responses were seen after administering the non-selective monoamine oxidase inhibitor pargyline and high, but not low, doses of the selective monoamine oxidase-B inhibitor deprenyl. Changes of tyrosine hydroxylase activity were observed only when subsaturated concentrations of the pteridine cofactor were used for the assay. The monoamine oxidase inhibitors altered the abundance of aromatic L-amino acid decarboxylase and tyrosine hydroxylase mRNA in the midbrain. Pargyline and high doses of deprenyl increased, aromatic L-amino acid decarboxylase mRNA, while clorgyline initially decreased and then increased it. All three compounds caused an early decrease of tyrosine hydroxylase mRNA. The acidic metabolites of dopamine appeared most affected by pargyline and clorgyline, supporting the notion that deamination of striatal dopamine in rodents is primarily by monoamine oxidase-A. Our results suggest, that striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase are apparently modulated via different mechanisms in response to p...Continue Reading

References

Jan 14, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·P C WaldmeierL Maître
Sep 1, 1992·Journal of Neurochemistry·X M LiA A Boulton
Mar 1, 1990·Journal of Neurochemistry·Z L RossettiM Hadjiconstantinou
Oct 1, 1990·Journal of Neurochemistry·J GrimsbyJ C Shih
Feb 1, 1989·Journal of Neurochemistry·Z RossettiM Hadjiconstantinou
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A W BachJ C Shih
Jul 1, 1968·Biochemical Pharmacology·J P Johnston
Apr 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·A M O'CarrollK F Tipton
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·J Knoll
Mar 15, 1995·European Journal of Pharmacology·M HadjiconstantinouN H Neff
Jun 1, 1993·Journal of Neurochemistry·M HadjiconstantinouN H Neff

❮ Previous
Next ❯

Citations

Oct 27, 1998·European Journal of Pharmacology·E A YoungM Hadjiconstantinou
Jul 31, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Hiam Abdala-ValenciaJoan M Cook-Mills
Nov 18, 2015·The Journal of Pharmacology and Experimental Therapeutics·David S GoldsteinYehonatan Sharabi
Dec 2, 2008·CNS Neuroscience & Therapeutics·Maria Hadjiconstantinou, Norton H Neff
Jan 31, 2017·The Journal of Pharmacy and Pharmacology·Gerard EstebanMercedes Unzeta
Feb 24, 2009·Molecular Genetics and Metabolism·George F G AllenSimon J R Heales

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.